Vinay Singh has a robust background encompassing strategic consulting, finance, and science. He has been consulting with life science companies since 2016 while at Blue Matter, with a focus in precision medicine and digital health. Prior to his work in strategy consulting, Vinay was in business development and financial advisory with Thomson Reuters and Burrill & Company, respectively. He also has research experience at Exelixis and has served in an Advisory Board capacity at MotionHall. Vinay earned a BS in Biology from Lehigh University and has a Series 63 license.